SpyGlass Pharma, Inc.
SGP
$26.20
$1.034.09%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | |||
|---|---|---|---|---|---|
| Net Income | -128.98% | -56.61% | -49.48% | ||
| Total Depreciation and Amortization | 155.22% | 156.45% | 101.58% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 218.64% | -13.35% | -68.09% | ||
| Change in Net Operating Assets | 62.60% | -18.95% | 292.35% | ||
| Cash from Operations | -134.61% | -65.15% | -49.35% | ||
| Capital Expenditure | -3,615.38% | -312.20% | 4.24% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -- | -- | -77.79% | ||
| Cash from Investing | -1,694.23% | -916.46% | -85.78% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | 181.82% | -45.00% | -86.12% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -100.00% | 220.79% | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | 93.43% | -19,364.29% | -- | ||
| Cash from Financing | -99.98% | 214.91% | -723.84% | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -122.76% | 241.58% | -367.36% | ||